Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development: a national heart, lung and blood institute workshop report
Alma Fulurija, Madeleine W Cunningham, Natalia Korotkova, Mary Y Masterson, Geetha P Bansal, Michael G Baker, Jeffrey W Cannon, Jonathan R Carapetis, Andrew C Steer · 2023
Read Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development: a national heart, lung and blood institute workshop report by Alma Fulurija, Madeleine W Cunningham, Natalia Korotkova, Mary Y Masterson, Geetha P Bansal, Michael G Baker, Jeffrey W Cannon, Jonathan R Carapetis, Andrew C Steer (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729269.txt.
Description
Alma Fulurija and co-authors report on a 2023 workshop about a vaccine against group A streptococcus. That germ causes sore throats, skin sores, and severe infections. It can also trigger rheumatic fever and lasting heart damage later. The burden falls hardest on young people in poor settings. No licensed vaccine exists yet, despite decades of work.
The report lists what blocks progress. Gaps remain in knowing how the germ interacts with the immune system and how to test safety. Animal models mimic human disease poorly, and funding has lagged. The authors call for more work on the germ's biology, better test models, a wider pool of vaccine candidates, and support for human trials.
Catalog record
| CREATOR | Alma Fulurija, Madeleine W Cunningham, Natalia Korotkova, Mary Y Masterson, Geetha P Bansal, Michael G Baker, Jeffrey W Cannon, Jonathan R Carapetis, Andrew C Steer |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |